[{"_id":"556b2aebfac443afdd39447c","決算期":"2015年3月期","証券コード":"4564","会社名":"オンコセラピー・サイエンス(株)【4564】","会計方式":"日本方式","決算発表日":"2015年5月15日","決算月数":"12か月","売上高":"769百万円","営業利益":"-1,962百万円","経常利益":"-1,939百万円","当期利益":"-1,334百万円","EPS（一株当たり利益）":"-9.09円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"105.22円","総資産":"16,608百万円","自己資本":"15,464百万円","資本金":"9,123百万円","有利子負債":"---","自己資本比率":"93.1%","ROA（総資産利益率）":"-7.58%","ROE（自己資本利益率）":"-8.29%","総資産経常利益率":"-11.02%","日付":"2015-05-31T15:38:20.036Z"},{"_id":"556b2aebfac443afdd39447f","決算期":"2014年3月期","証券コード":"4564","会社名":"オンコセラピー・サイエンス(株)【4564】","会計方式":"日本方式","決算発表日":"2014年5月15日","決算月数":"12か月","売上高":"1,017百万円","営業利益":"-3,785百万円","経常利益":"-3,767百万円","当期利益":"-3,676百万円","EPS（一株当たり利益）":"-28.20円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"113.95円","総資産":"18,579百万円","自己資本":"16,723百万円","資本金":"9,082百万円","有利子負債":"---","自己資本比率":"90.0%","ROA（総資産利益率）":"-24.41%","ROE（自己資本利益率）":"-28.16%","総資産経常利益率":"-25.01%","日付":"2015-05-31T15:38:20.036Z"},{"_id":"556b2aebfac443afdd394480","決算期":"2013年3月期","証券コード":"4564","会社名":"オンコセラピー・サイエンス(株)【4564】","会計方式":"日本方式","決算発表日":"2013年5月15日","決算月数":"12か月","売上高":"3,277百万円","営業利益":"-1,113百万円","経常利益":"-1,113百万円","当期利益":"-1,103百万円","EPS（一株当たり利益）":"-5,113.65円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"43,398.39円","総資産":"11,543百万円","自己資本":"9,387百万円","資本金":"3,573百万円","有利子負債":"---","自己資本比率":"81.3%","ROA（総資産利益率）":"-9.09%","ROE（自己資本利益率）":"-11.11%","総資産経常利益率":"-9.18%","日付":"2015-05-31T15:38:20.036Z"}]